Summary
Machine-generated summaryThe French research organisation Inserm, through its research unit UMR 1190, is procuring experimental research and development services consisting of multi-omics analyses, namely proteomics and, where required, metabolomics, on precious and limited human pancreatic islet samples. The contract covers sample receipt, verification and storage, analytical workflows, a pilot phase with associated deliverables, quality control and data validation, bioinformatic pre-processing and delivery of standardised data, return of unused biological material, communication, reporting and client support, plus administrative and logistics costs linked to subcontracting and shipping. The contract is funded through the PreciseIT project under the Strategic Research Agreement call of Breakthrough T1D. Estimated value and submission deadline are not stated in the notice.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago
Change history
Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.
-
Read before bidding
- Submission deadline: Extended by 1 day: now September 3, 2026, 12:00
-
Act now
- Submission deadline: Moved 1 day EARLIER: now September 3, 2026, 00:00
- Scope and criteria: The description was expanded. Re-read it before you bid.
Follow this tender and we email you the moment it changes. Create account
Similar tenders
12
days left
€108,833
est. value
19
days left
€108,333
est. value
Market context
- Avg. open tender · Research & development
- €3,272,461
- Buyer track record on Aperlena
- 2 notices tracked · 0 awarded
Never miss a tender like this
2 new notices in Research & development in France in the last 7 days. Get an email when new ones appear. Free.
Set up my alert